Doctors discover a life saving drug in Viagra

Viagra, the drug that treats male impotence has a vital ingredient that can treat pulmonary hypertension [PPH], a serious vascular disease. Dr Mohamed Khalifa of Pfizer pharmaceuticals detailed this Viagra breakthrough to a group of leading Omani practitioners recently.

Doctors claim it a significant breakthrough as the life expectancy of a patient diagnosed with PPH is only two years and eight months. Viagra, already approved by the U.S Food and Drug Administration to treat PPH, expects to improve the life expectancy of people who suffer from the disease.

PPH is a severe condition in which the high blood pressure moves from the heart to the lungs resulting in fatigue, dizziness and breathing difficulties. It affects people irrespective of their age or gender.

Pfizer's commitment to develop cures for all types of medical disorders gets a good start with Viagra, an extremely safe oral therapy drug. The doctors witnessed improvements in patients who took the clinical trial by covering a six-mile walk. It is a standard efficacy of pulmonary arterial hypertension trials after taking Viagra.

Today 23 million men all over the world take Viagra. It is in high demand amongst the youngsters in Dubai since the last four years.